Pandora Media Inc (NYSE:P) shares moved down -0.36% in last trading session and ended the day at $19.19. P Gross Margin is 46.10% and its has a return on assets of -7.30%. Pandora Media Inc (NYSE:P) quarterly performance is 20.24%.
Pandora (NYSE: P) reported Q3 EPS of $0.10, in-line with the analyst estimate of $0.10. Revenue for the quarter came in at $311.6 million versus the consensus estimate of $312.97 million. Pandora sees Q4 2015 revenue of $325-330 million, versus the consensus of $351.84 million.
Intrexon Corporation (NYSE:XON) ended the last trading day at $30.98. Company weekly volatility is calculated as 8.25% and price to cash ratio as 21.35. Intrexon Corporation (NYSE:XON) showed a weekly performance of -7.47%.
On 8 October, Intrexon Corporation (NYSE:XON), announced the appointment of Joseph L. Vaillancourt as Senior Vice President, Head of Environment Sector, succeeding Nir Nimrodi who continues in his role as Head of Corporate Development. Mr. Vaillancourt will direct Intrexon’s endeavors to generate sustainable, biologically based solutions to environmental problems.
On 22 October, Web.com Group, Inc. (NASDAQ:WWWW) shares moved up 1.99% and was closed at $23.04. WWWW EPS growth in last 5 year was -43.10%. Web.com Group, Inc. (NASDAQ:WWWW) year to date (YTD) performance is 21.33%.
Web.com Group, Inc. (NASDAQ:WWWW), a leading provider of Internet services and online marketing solutions for small businesses, announced it will report its third quarter results for the fiscal period ended September 30, 2015, after the U.S. financial markets close on Thursday, October 29, 2015.
NewLink Genetics Corporation (NASDAQ:NLNK) shares moved up 2.11% in last trading session and ended the day at $35.78. NLNK has a return on assets of 57.30%. NewLink Genetics Corporation (NASDAQ:NLNK) quarterly performance is -30.98%.
On 13 October, NewLink Genetics Corporation (NASDAQ:NLNK), announced that a peer-reviewed article in Cell Reports offers new insight demonstrating that the tumor indoleamine 2,3-dioxygenase (IDO) pathway is a central regulator of both local and systemic immunosuppression and resistance to immunotherapy in melanoma.
PharMerica Corporation (NYSE:PMC) caters to the Services space. It has a net profit margin of 1.20% and weekly performance is -2.57%. On the last day of trading company shares ended up at $28.00. PharMerica Corporation (NYSE:PMC) distance from 50-day simple moving average (SMA50) is -10.69%.
On 20 October, PharMerica Corporation (NYSE:PMC), a national provider of institutional, specialty home infusion, hospital and oncology pharmacy services, announced that it has completed the acquisition of McGuire Group Pharmacy (“McGuire”). Terms of the transaction were not disclosed.
Leave a Reply